Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

publication venue for

A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. 2011
Infection of epicardial pacemaker wires due to Mycobacterium abscessus. 1998
Reply to Diekema et al. "Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?". 2023
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.. 77. 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients with Pneumonia: A Prospective Observational Study. 2023
Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV. 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions. 2023
The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination. 2023
Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank. 2023
T-SPOT.TB reactivity in Southern African children with and without in utero HIV exposure. 2023
Predictors of Coronavirus Disease 2019 Hospitalization After Sotrovimab in Patients With Hematologic Malignancy During the BA.1 Omicron Surge.. 76. 2023
Immunogenicity and Safety of Hepatitis B vaccine with a Toll-like Receptor 9 Agonist Adjuvant (HEPLISAV-B) in HBV Vaccine-naive People with HIV. 2023
The epidemiology of long COVID in US adults. 2022
REPORTing of Antimicrobial Resistance from Blood Cultures (REPORT-ABC), an ARLG Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. 2022
Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and Lactation.. 75. 2022
Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880-2018: A Systematic Review.. 75. 2022
Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19. 2022
Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021.. 75. 2022
Sex-Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation among People with HIV in the U.S. 2022
Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.. 75. 2022
Transcriptional analysis for tuberculosis in pregnant women from the PRACHITi study. 2022
Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes after Bacteremia Caused by Carbapenem-Resistant Enterobacterales. 2022
Risk of Healthcare-Associated Transmission of Sever Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Hospitalized Cancer Patients.. 74. 2022
The Impact of Vitamin A Deficiency on Tuberculosis Progression. 2022
Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy. 2022
A randomized clinical trial of HPV test-and-treat as compared to cytology-based screening for prevention of cervical cancer among women living with HIV: AIDS Clinical Trials Group Protocol A5282. 2022
The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection.. 74. 2022
Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials. 2022
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents. 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients With Coronavirus Disease 2019.. 73. 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance and Exposure in the Perioperative Setting With Universal Testing and Personal Protective Equipment Policies.. 73. 2021
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.. 73. 2021
Severity, criticality, and fatality of the SARS-CoV-2 Beta variant. 2021
Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City. 2021
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.. 73. 2021
Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti. 2021
National Landscape of HIV+ Deceased Organ Donors in the United States. 2021
DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study.. 73. 2021
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women. 2021
Congenital human cytomegalovirus infection is associated with decreased transplacental IgG transfer efficiency due to maternal hypergammaglobulinemia. 2021
The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities.. 72. 2021
Factors Associated with Readmission in the US Following Hospitalization with COVID-19. 2021
Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States.. 72. 2021
Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19.. 72. 2021
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND).. 72. 2021
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.. 71. 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.. 71. 2020
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting. 2020
Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing Position Statements on Polymyxin B and Colistin Clinical Breakpoints.. 71. 2020
Diphtheria Antitoxin Administration, Outcomes, and Safety: Response to a Diphtheria Outbreak in Cox's Bazar Bangladesh. 2020
SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study. 2020
Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients.. 71. 2020
Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19. 2020
HPV Vaccination Prior to Loop Electroexcision Procedure does not Prevent Recurrent Cervical High Grade Squamous Intraepithelial Lesions in Women Living with HIV: a Randomized, Double-blind, Placebo-controlled Trial. 2020
Efavirenz Pharmacogenetics and Weight Gain following Switch to Integrase Inhibitor-containing Regimens. 2020
Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV. 2020
Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES.. 71. 2020
Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus.. 70. 2020
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs.. 70. 2020
Hepatitis C Virus (HCV) Treatment With Directly Acting Agents Reduces the Risk of Incident Diabetes: Results From Electronically Retrieved Cohort of HCV Infected Veterans (ERCHIVES).. 70. 2020
Serotypes of Streptococcus pneumoniae in Children Aged <5 Years Hospitalized With or Without Pneumonia in Developing and Emerging Countries: A Descriptive, Multicenter Study.. 70. 2020
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.. 70. 2020
Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities.. 69. 2019
Clinical Performance of (1,3) Beta-D Glucan for the Diagnosis of Pneumocystis Pneumonia (PCP) in Cancer Patients Tested With PCP Polymerase Chain Reaction.. 69. 2019
Frailty Is an Independent Risk Factor for Mortality, Cardiovascular Disease, Bone Disease, and Diabetes Among Aging Adults With Human Immunodeficiency Virus.. 69. 2019
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.. 69. 2019
Optimizing Contact Precautions to Curb the Spread of Antibiotic-resistant Bacteria in Hospitals: A Multicenter Cohort Study to Identify Patient Characteristics and Healthcare Personnel Interactions Associated With Transmission of Methicillin-resistant Staphylococcus aureus.. 69. 2019
Improved Outcomes With High-dose Isoniazid in Multidrug-resistant Tuberculosis Treatment in Haiti.. 69. 2019
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.. 69. 2019
New Avenues for Antimicrobial Stewardship: The Case for Penicillin Skin Testing by Pharmacists.. 68. 2019
A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial.. 68. 2019
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.. 68. 2019
Trends in Treatment Uptake and Provider Specialty for Hepatitis C Virus (HCV) Infection in the Veterans Affairs Healthcare System: Results From the Electronically Retrieved Cohort of HCV-Infected Veterans (ERCHIVES).. 68. 2019
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.. 67. 2018
A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.. 67. 2018
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer.. 67. 2018
Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells.. 67. 2018
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.. 67. 2018
Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis.. 67. 2018
Association of Neighborhood Socioeconomic Status With Risk of Infection and Sepsis.. 66. 2018
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)-infected Participants With HIV-1 RNA <500000 Copies/mL.. 66. 2018
Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial.. 66. 2018
State Medicaid Hepatitis C Treatment Eligibility Criteria and Use of Direct-Acting Antivirals.. 66. 2018
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.. 66. 2018
Trends in Invasive Pneumococcal Disease in Cancer Patients After the Introduction of 7-valent Pneumococcal Conjugate Vaccine: A 20-year Longitudinal Study at a Major Urban Cancer Center.. 66. 2018
Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort Study.. 65. 2017
Outbreak of Influenza A(H7N2) Among Cats in an Animal Shelter With Cat-to-Human Transmission-New York City, 2016.. 65. 2017
Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.. 65. 2017
Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES.. 65. 2017
Microorganisms Associated With Pneumonia in Children <5 Years of Age in Developing and Emerging Countries: The GABRIEL Pneumonia Multicenter, Prospective, Case-Control Study.. 65. 2017
Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES.. 65. 2017
From One Syndrome to Many: Incorporating Geriatric Consultation Into HIV Care.. 65. 2017
Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES.. 65. 2017
Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.. 65. 2017
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.. 64. 2017
Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk.. 64. 2017
High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines.. 64. 2016
Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.. 63. 2016
Baseline, Time-Updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.. 63. 2016
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.. 63. 2016
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.. 63. 2016
Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.. 63. 2016
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.. 63. 2016
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?. 62. 2016
Clinical and Pathological Evaluation of Mycobacterium marinum Group Skin Infections Associated With Fish Markets in New York City.. 62. 2015
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.. 62. 2015
Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits.. 61 Suppl 6. 2015
Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.. 61 Suppl 6. 2015
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.. 61 Suppl 6. 2015
Measles in the 21st Century, a Continuing Preventable Risk to Travelers: Data From the GeoSentinel Global Network.. 62. 2015
Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.. 61. 2015
Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.. 61. 2015
Weight change after antiretroviral therapy and mortality.. 60. 2015
The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia.. 60. 2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).. 60. 2015
T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.. 60. 2015
The clinical role and cost-effectiveness of long-acting antiretroviral therapy.. 60. 2015
Clinical and microbiological determinants of infection after transrectal prostate biopsy.. 60. 2014
Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.. 59 Suppl 7. 2014
Using clinicians' search query data to monitor influenza epidemics.. 59. 2014
A paradigm shift: focus on the HIV prevention continuum.. 59 Suppl 1. 2014
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.. 59. 2014
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.. 59. 2014
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.. 59. 2014
Deaths among people with hepatitis C in New York City, 2000-2011.. 58. 2014
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.. 58. 2014
Antiretroviral therapy for the prevention of HIV transmission: what will it take?. 58. 2014
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.. 58. 2013
Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans.. 58. 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.. 58. 2013
Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.. 57. 2013
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.. 57. 2013
The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.. 57. 2013
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.. 57. 2013
Forecasting high-priority infectious disease surveillance regions: a socioeconomic model.. 56. 2012
Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity.. 56. 2012
Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011).. 55. 2012
Recent successes and noteworthy future prospects in the treatment of chronic hepatitis C.. 55 Suppl 1. 2012
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.. 55. 2012
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.. 55. 2012
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.. 55. 2012
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.. 54 Suppl 4. 2012
HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation.. 55. 2012
Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.. 55. 2012
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. 54. 2012
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.. 54. 2012
Global TravEpiNet: a national consortium of clinics providing care to international travelers--analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009-2011.. 54. 2011
Relapse versus reinfection: surveillance of Clostridium difficile infection.. 53. 2011
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.. 53. 2011
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women.. 52. 2011
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT.. 52. 2011
Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.. 52. 2011
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.. 52. 2011
Antimicrobial-resistant nocardia isolates, United States, 1995-2004.. 51. 2010
Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.. 51. 2010
Rapidly growing mycobacteria infection in patients with cancer.. 51. 2010
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.. 50. 2010
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.. 50. 2010
Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India.. 50. 2010
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.. 49. 2009
Hepatitis C virus infection and the risk of coronary disease.. 49. 2009
Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.. 49. 2009
Long-term serologic follow-up of isolated hepatitis B core antibody in HIV-infected and HIV-uninfected women.. 49. 2009
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.. 48. 2009
High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy.. 48. 2009
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.. 48. 2009
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.. 48. 2009
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.. 47. 2008
Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.. 47. 2008
Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.. 46. 2008
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.. 46 Suppl 4. 2008
Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.. 46. 2008
A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004.. 46 Suppl 3. 2008
Monitoring the safety of a smallpox vaccination program in the United States: report of the joint Smallpox Vaccine Safety Working Group of the advisory committee on immunization practices and the Armed Forces Epidemiological Board.. 46 Suppl 3. 2008
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.. 46. 2008
Persistent and relapsing babesiosis in immunocompromised patients.. 46. 2008
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?. 45. 2007
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.. 45. 2007
Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions.. 45. 2007
Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection.. 44. 2007
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment.. 44. 2007
HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.. 44. 2007
Listeria monocytogenes infection from foods prepared in a commercial establishment: a case-control study of potential sources of sporadic illness in the United States.. 44. 2007
Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response.. 43. 2006
Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children.. 43. 2006
The risk of tuberculosis in patients with cancer.. 42. 2006
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.. 42. 2006
Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.. 42. 2005
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.. 42. 2005
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).. 41. 2005
Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis.. 40. 2005
Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study.. 39. 2004
Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study.. 39. 2004
Signs and symptoms predictive of death in patients with foodborne botulism--Republic of Georgia, 1980-2002.. 39. 2004
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.. 39. 2004
Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.. 38 Suppl 4. 2004
Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology.. 38. 2004
Why don't they listen? Adherence to recommendations of infectious disease consultations.. 38. 2004
The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women.. 38. 2004
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.. 38. 2004
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.. 37. 2003
Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women.. 37. 2003
Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.. 37. 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.. 36. 2003
Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.. 36. 2003
Personal digital assistant infectious diseases applications for health care professionals.. 36. 2003
Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection.. 36. 2003
Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.. 36. 2003
Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas.. 35. 2002
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media.. 35. 2002
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar media.. 35. 2002
National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.. 35. 2002
Hepatitis C information on the world wide web.. 35. 2002
Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.. 35. 2002
Infections caused by viridans streptococci in patients with neutropenia.. 34. 2002
Rhodococcus equi: an emerging pathogen.. 34. 2002
Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites.. 34. 2002
Impact of a hospital-based antimicrobial management program on clinical and economic outcomes.. 33. 2001
Mycobacterium haemophilum in immunocompromised patients.. 33. 2001
Candida dubliniensis at a cancer center.. 32. 2001
Adenovirus infections in adult recipients of blood and marrow transplants.. 32. 2001
Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.. 32. 2001
Infection of orthopedic prostheses after Staphylococcus aureus bacteremia.. 32. 2001
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.. 32. 2001
Adequacy of fellowship training: results of a survey of recently graduated fellows.. 32. 2001
Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.. 31. 2000
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.. 31. 2000
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.. 31. 2000
Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.. 31. 2000
Short-course of oral miltefosine for treatment of visceral leishmaniasis.. 31. 2000
Nose blowing propels nasal fluid into the paranasal sinuses.. 30. 2000
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.. 30. 2000
Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil.. 30. 2000
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.. 29. 1999
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.. 28. 1999
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.. 27. 1998
Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases.. 27. 1998
Atovaquone alone or with fluconazole as oral therapy for Indian kala-azar.. 27. 1998
Endogenous interleukin-2 serum levels in children infected with human immunodeficiency virus.. 25. 1997
Infectious ocular complications in orthotopic liver transplant patients.. 24. 1997
Polymerase chain reaction analysis of distal vaginal specimens: a less invasive strategy for detection of Trichomonas vaginalis.. 24. 1997
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.. 23 Suppl 1. 1996
Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa.. 23. 1996
Foscarnet therapy for cytomegalovirus infection after allogeneic bone marrow transplantation.. 22. 1996
Lung abscess in patients with AIDS.. 22. 1996
Tuberculosis among urban health care workers: a study using restriction fragment length polymorphism typing.. 21. 1995
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.. 21. 1995
Parainfluenza and influenza virus infections in pediatric organ transplant recipients.. 20. 1995
Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.. 17. 1993
Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis.. 15. 1992
Sepsis due to Rhodotorula related to use of indwelling central venous catheters.. 14. 1992
Reply to Roussel et al.. 72. 2021
Missed Opportunities With Fatal Consequences: The Need for Earlier Initiation of Intensified Care for Patients at Highest Risk of Mortality From Human Immunodeficiency Virus-Associated Tuberculosis.. 71. 2020
Necessary but Not Sufficient: The Need for Innovative Strategies to Enhance Retention and Viral Suppression After Rapid Initiation of Antiretroviral Therapy.. 71. 2020
Frailty Is Associated With Insulin Resistance in Chronic Human Immunodeficiency Virus Infection.. 71. 2020
Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?. 70. 2020
Reply to Brijwal et al.. 68. 2019
Reply to Meijide et al.. 64. 2016
Tolerability of Fluoroquinolones in Management of Latent Tuberculosis in Liver Transplant Candidates.. 61. 2015
Reply to Bauer and Goff.. 61. 2015
Reply to Yamamoto et al.. 58. 2014
Cost-effectiveness of fidaxomicin for Clostridium difficile treatment.. 58. 2013
Reply to King and Stover.. 58. 2013
Reply to Mikulska et al.. 57. 2013
In memoriam: James J. Rahal Jr, MD.. 53. 2011
Guideline tyranny: a response to the article by Baum and Kaltsas.. 47. 2008
Guideline tyranny: primum non nocere.. 46. 2008
The difference between adequate and appropriate antimicrobial treatment.. 46. 2008
Preventing vertical hepatitis C virus transmission.. 45. 2007
Attributable mortality of Acinetobacter baumannii infection among critically ill patients.. 43. 2006
Do not abandon amphotericin B as an antifungal bladder irrigant.. 41. 2005
Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux.. 40. 2005
Antimicrobial mechanisms of cranberry juice.. 39. 2004
Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections.. 39. 2004
Hospital-acquired and community-derived: the future of MRSA?. 37. 2003
Septic joint replacement: an orthopedic perspective.. 34. 2002
Transmission of tuberculosis during medical procedures.. 25. 1997
Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer--is it justified?. 25. 1997
Viral taxonomy.. 25. 1997
Long-term suppressive therapy for fungal endocarditis.. 23. 1996
Treatment of human immunodeficiency virus-related thrombocytopenia with intravenous anti-rhesus D immunoglobulin.. 22. 1996
Vibrio parahaemolyticus septicemia in a patient with neutropenic leukemia.. 15. 1992
Use of an Electronic Medical Record Alert. 2021
Reply to Rhoads, et al. 2021
Epidemiology of Bordetella pertussis Among Patients With Cancer. 2020
Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential? 2018
Switching from efavirenz to nevirapine. 2010
Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio. 2009
Thrombocytopenia and Borrelia burgdorferi: an association remains unproven. 1999
Leukopenia, thrombocytopenia, and Lyme borreliosis: is there an association? 1997
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia. 2010
Editorial commentary: Antibiotic self-treatment of travelers' diarrhea: helpful or harmful?. 60. 2015
The effect of antiretrovirals on vitamin D.. 52. 2011
Micronutrient Supplementation as Adjunct Treatment for HIV-Infected Patients.. 50. 2010
Low bone mineral density, HIV infection, and women: fracture or fiction?. 42. 2006
Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.. 39. 2004
Devising strategies for preventing nosocomial pneumonia--should we ignore the stomach?. 24. 1997
Lessons From COVID-19 in Children: Key Hypotheses to Guide Preventative and Therapeutic Strategies. 2020
Carbapenemase-Producing Organisms: A Global Scourge. 2018
Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature. 2013
A pill for HIV prevention: déjà vu all over again? 2013
When to start antiretroviral therapy? 2008
Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. 2008
An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. 2007
Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care. 2006
Efficacy of safety-engineered device implementation in the prevention of percutaneous injuries: a review of published studies. 2006
Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms. 2006
Hepatitis A and B booster recommendations: implications for travelers. 2005
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin. 2005
Infectious disease experimentation involving human volunteers. 2002
Influence of interleukin-1 receptor antagonist gene polymorphism on disease. 2001
Acute paranasal sinusitis in critically ill patients: guidelines for prevention, diagnosis, and treatment. 1997
Dual respiratory virus infections. 1997
Cyclospora: an overview. 1996
Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018. 2022
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria. 2022
Echinocandins: The Expanding Antifungal Armamentarium. 2015
Diagnosing and managing diabetes in HIV-infected patients: current concepts. 2014
Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. 2013
Human granulocytic anaplasmosis during pregnancy: case series and literature review. 2007
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. 2006
Bone disorders in human immunodeficiency virus infection. 2003
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. 2002
Coronary artery disease and human immunodeficiency virus infection. 2000
Successful treatment of fungal prosthetic valve endocarditis: case report and review. 1996
Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. 1994
Therapy for neurocysticercosis: a reappraisal. 1993
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. 2003

VIVO Weill Cornell Medical College

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)